September 18, 2012 7:24 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top drug stores stocks in terms of revenue estimate for the current year.Analysts expect CVS Caremark (NYSE: CVS) to post revenue of $122.80 billion for the year ending December, 2012. CVS Caremark's trailing-twelve-month revenue is $116.50 billion.Walgreen Co (NYSE: WAG) is expected to report revenue of $71.73 billion for the year ending August, 2012. Walgreen's trailing-twelve-month revenue is $72.53 billion.Rite Aid (NYSE: RAD) is likely to post revenue of $25.42 billion in the year ending February, 2013. Rite Aid's trailing-twelve-month revenue is $26.20 billion.GNC Holdings (NYSE: GNC) may report revenue of $2.43 billion in the year ending December, 2012. GNC Holdings' trailing-twelve-month revenue is $2.29 billion.PharMerica (NYSE: PMC) is estimated to post revenue of $1.84 billion in the year ending December, 2012. PharMerica's trailing-twelve-month revenue is $1.97 billion.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.